English

Year-End Report 1 January – 31 December 2020

Report this content

”Significant growth ended the year”

1 OCTOBER – 31 DECEMBER 2020 (3 MONTHS)

  • Net sales increased by 75 percent to SEK 1,731 million (988), of which organic growth amounted to 51 percent and acquired growth amounted to 29 percent.
  • EBITA increased by 208 percent to SEK 316 million (102), corresponding to an EBITA-margin of 18.2 percent (10.4).
  • Profit after tax increased by 343 percent to SEK 219 million (49).
  • Earnings per share amounted to SEK 1.94 (0.44).
  • Cash flow from operating activities amounted to SEK 559 million (175).
  • During the quarter, four acquisitions has been completed and expected annual net sales amounts to approximately SEK 355 million.

1 JANUARY – 31 DECEMBER 2020 (12 MONTHS)

  • Net sales increased by 52 percent to SEK 5,273 million (3,479), of which organic    growth amounted to 38 percent and acquired growth amounted to 17 percent.
  • EBITA increased by 163 percent to SEK 802 million (305), corresponding to an EBITA-margin of 15.2 percent (8.8).
  • Profit after tax increased by 265 percent to SEK 520 million (142).
  • Earnings per share amounted to SEK 4.63 (1,28).
  • Cash flow from operating activities amounted to SEK 950 million (400).
  • The equity ratio was 46 percent (45).
  • Return on working capital (P/WC) amounted to 103 percent (51).
  • During the financial year, six acquisitions have been completed, with a combined annual sale of about SEK 650 million.
  • The Board of directors proposes a dividend of SEK 1.50 per share.

Stockholm, 3 February 2021 AddLife AB (publ)

For more information, contact;
Kristina Willgård, CEO, kristina.willgard@add.life, +46 70 510 12 23
Martin Almgren, CFO, martin.almgren@add.life, +46 70 228 15 45
www.add.life

 

Teleconference

Investors. analysts and the media are invited to a teleconference at which CEO Kristina Willgård and CFO Martin Almgren will present the interim report. The presentation will be given in English and take about 20 minutes. after which there will be an opportunity to ask questions.

The teleconference will be at 3 p.m. on 3 February 2021
The presentation will be available via the following link: Webcast
To participate via telephone, please see link: Call in details

 

AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has about 1,100 employees in some 50 operating subsidiaries. The Group currently has net sales of around SEK 5 billion. AddLife shares are listed on Nasdaq Stockholm.

This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 3 February 2021 at 1 p.m. CET.
 

Subscribe

Documents & Links